A single centre study to investigate the real world effectiveness of ledipasvir/sofosbuvir in patients with chronic hepatitis C.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 17 Apr 2016 Preliminary results (n=110) were presented at The International Liver Congress™ 2016.
- 15 Aug 2015 New trial record